Ivana Magovcevic-liebisch - Net Worth and Insider Trading
Ivana Magovcevic-liebisch Net Worth
The estimated net worth of Ivana Magovcevic-liebisch is at least $2 Million dollars as of 2024-12-28. Ivana Magovcevic-liebisch is the EVP; COO of Dyax Corp and owns about 40,625 shares of Dyax Corp (DYAX) stock worth over $2 Million. Ivana Magovcevic-liebisch is the President and CEO of Vigil Neuroscience Inc and owns about 222,687 shares of Vigil Neuroscience Inc (VIGL) stock worth over $367,434. Ivana Magovcevic-liebisch is also the Director of Applied Genetic Technologies Corp and owns about 3,000 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $1,181. Details can be seen in Ivana Magovcevic-liebisch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ivana Magovcevic-liebisch has not made any transactions after 2024-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ivana Magovcevic-liebisch owns 5 companies in total, including Spyre Therapeutics Inc (SYRE) , Applied Genetic Technologies Corp (AGTC) , and Dyax Corp (DYAX) among others .
Click here to see the complete history of Ivana Magovcevic-liebisch’s form 4 insider trades.
Insider Ownership Summary of Ivana Magovcevic-liebisch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2018-03-22 | director |
| AGTC | Applied Genetic Technologies Corp | 2016-11-16 | director |
| DYAX | Dyax Corp | 2013-03-29 | EVP; Chief Operating Officer |
 | | 2021-07-21 | director |
| | 2024-12-05 | director & President and CEO |
Ivana Magovcevic-liebisch Latest Holdings Summary
Ivana Magovcevic-liebisch currently owns a total of 3 stocks. Among these stocks, Ivana Magovcevic-liebisch owns 40,625 shares of Dyax Corp (DYAX) as of March 6, 2013, with a value of $2 Million and a weighting of 80.89%. Ivana Magovcevic-liebisch owns 222,687 shares of Vigil Neuroscience Inc (VIGL) as of December 19, 2024, with a value of $367,434 and a weighting of 19.05%. Ivana Magovcevic-liebisch also owns 3,000 shares of Applied Genetic Technologies Corp (AGTC) as of November 16, 2016, with a value of $1,181 and a weighting of 0.06%.
Latest Holdings of Ivana Magovcevic-liebisch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYAX | Dyax Corp | 2013-03-06 | 40,625 | 38.41 | 1,560,406 |
| VIGL | Vigil Neuroscience Inc | 2024-12-19 | 222,687 | 1.65 | 367,434 |
| AGTC | Applied Genetic Technologies Corp | 2016-11-16 | 3,000 | 0.39 | 1,181 |
Holding Weightings of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Form 4 Trading Tracker
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 215,359 shares on March 6, 2013, which brought Ivana Magovcevic-liebisch around $861,436.
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 5 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Vigil Neuroscience Inc is the acquisition of 5,000 shares on December 19, 2024, which cost Ivana Magovcevic-liebisch around $8,400.
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the acquisition of 3,000 shares on November 16, 2016, which cost Ivana Magovcevic-liebisch around $28,890.
Insider Trading History of Ivana Magovcevic-liebisch
- 1
Ivana Magovcevic-liebisch Trading Performance
GuruFocus tracks the stock performance after each of Ivana Magovcevic-liebisch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ivana Magovcevic-liebisch is 25.08%. GuruFocus also compares Ivana Magovcevic-liebisch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ivana Magovcevic-liebisch within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ivana Magovcevic-liebisch's insider trading performs compared to the benchmark.
Performance of Ivana Magovcevic-liebisch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.27 | | | | | |
| Relative Return to S&P 500(%) | -2.34 | | | | | |
Ivana Magovcevic-liebisch Ownership Network
Ivana Magovcevic-liebisch Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Ivana Magovcevic-liebisch is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
Over the past 18 months, Ivana Magovcevic-liebisch made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .
In summary, during the past 3 months, insiders sold 7,000 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
Ivana Magovcevic-liebisch Mailing Address
Above is the net worth, insider trading, and ownership report for Ivana Magovcevic-liebisch. You might contact Ivana Magovcevic-liebisch via mailing address: 300 Technology Square, 8th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
